Alcresta Therapeutics

Alcresta Therapeutics is the developer of enzyme-based products designed to combat gastrointestinal disorders. Alcresta Therapeutics was acquired by Linden Capital Partners in March 2024.

ACQUIRED BY: LINDEN CAPITAL PARTNERS

Investors

Steve Kraus

Founded

2011

Partnered

2011

Roadmaps